| Net Cash Provided by (Used in) Operating Activities |
$108,469,000 |
USD |
363% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$354,990,000 |
USD |
1.3% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$307,268,000 |
USD |
0.8% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
161,834,837 |
shares |
-4% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$65,605,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$194,495,000 |
USD |
-17% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$134,316,000 |
USD |
-24% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
-100% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$117,522,000 |
USD |
138% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$310,710,000 |
USD |
-143% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$81,883,000 |
USD |
270% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$2,257,078,000 |
USD |
-1.5% |
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
$7,000,000 |
USD |
141% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$1,100,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
$741,405,000 |
USD |
51% |
Q1 2024 |
Q1 2024 |